Osteoporosis and breast cancer
Authors:
- Elisabeth FontangesEFElisabeth Fontanges
- Aurélie FontanaAFAurélie Fontana
- Pierre DelmasPDPierre Delmas
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Joint Bone Spine
- Vol. 71 (2) , 102-110
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Epidemiology and outcomes of osteoporotic fracturesThe Lancet, 2002
- Prevention of Bone Loss with Tibolone in Postmenopausal Women: Results of Two Randomized, Double-Blind, Placebo-Controlled, Dose-Finding StudiesThe Journal of Clinical Endocrinology & Metabolism, 2001
- Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast CancerAnnals of Internal Medicine, 1999
- Hormonal Predictors of Bone Loss in Elderly Women: A Prospective StudyJournal of Bone and Mineral Research, 1998
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Hormone replacement therapy in the prevention and treatment of osteoporosisOsteoporosis International, 1997
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987